Why is Marksans Pharma falling/rising?

As of 18-Aug, Marksans Pharma Ltd's stock price is currently at Rs 184.10, reflecting an increase of Rs 5.8 or 3.25%. Despite this positive movement today, the stock has underperformed significantly over the past week and month, with declines of 12.75% and 28.28% respectively. The stock is trading below its moving averages across all time frames, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 29.64% compared to the 5-day average. While the company boasts a high return on equity (ROE) of 17.66% and low debt levels, it has faced challenges such as a decline in operating profit growth and negative quarterly results, which have contributed to its recent price movements.
In the broader market context, the stock's performance has been considerably weaker than the benchmark, with a one-year return of -11.85% compared to the Sensex's gain of 1.04%. This stark contrast highlights the stock's struggles relative to the overall market, particularly as it has underperformed even in a generally negative market environment. The company's recent financial results, including a significant drop in profit after tax and low inventory turnover, further exacerbate concerns about its long-term growth prospects. Although institutional holdings are relatively high at 25.38%, indicating some level of confidence from more sophisticated investors, the overall sentiment remains cautious due to the company's recent performance and valuation concerns.